GlassScriptPhysician profile
Megan E Harrison
NPI 1528686128
$2,080.60
in general payments reported to CMS, 2019-2025
19 companies · $671 in 2025
The $671 reported for 2025 was more than what 91% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $136 · 2023: $251 · 2024: $767 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $397.20 | 2024-2025 | |
| Sage Therapeutics, LLC | $263.22 | 2023-2025 | Zurzuvae |
| Novo Nordisk INC | $228.49 | 2021-2025 | Wegovy |
| Astellas Pharma US INC | $176.55 | 2024-2025 | Veozah |
| Abbvie INC. | $129.41 | 2021-2025 | |
| Organon LLC | $124.49 | 2021-2025 | Nexplanon |
| Pfizer INC. | $122.77 | 2021-2024 | |
| Biogen, INC. | $119.33 | 2025 | Zurzuvae |
| Boston Scientific Corporation | $100.99 | 2025 | Axonics |
| Axonics, INC. | $77.52 | 2023-2024 | Axonics |
| Hologic Sales and Service, LLC | $76.82 | 2023-2024 | Thinprep 2000 Processor, Aptima, Novasure |
| Sumitomo Pharma America, INC. | $66.71 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $64.95 | 2021 | |
| Gynesonics, INC. | $52.63 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $16.80 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $16.63 | 2022 | |
| Smith+Nephew, INC. | $16.51 | 2021 | |
| Exeltis, USA INC. | $15.21 | 2024 | Slynd |
| Seqirus USA INC | $14.37 | 2025 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.